Scientists Found an Unexpected Toxin Floating in the Oklahoma Sky
Scientists at the University of Colorado Boulder have now, in a first for North American, detected these toxins in the air while researching aerosol formation.
These airborne MCCPs particles likely entered the atmosphere through biosolids—a fertilizer developed from treated wastewater.
One of the downsides of modern life is the proliferation of chemicals in the natural environment. Arguably the most well-known of these chemical culprits are per- and polyfluoroalkyl substances (PFAS), which are used for stuff like non-stick surfaces on frying pans. They are also known as 'forever chemicals' for their tendency to linger in the environment.
But this environmental scourge is only one of many similar substances. Of the others, one of the most concerning is a type of toxin known as medium-chain chlorinated paraffins, or MCCPs. Like PFAS, these chemicals take a longtime to break down, and have been shown to be the driver behind health issues like liver and kidney toxicity, thyroid malfunction, and certain neurological issues. MCCPs have been detected in the atmosphere on other continents (including Asia and even Antarctica) but a new study from the University of Colorado Boulder claims that North America has now joined that unlucky list.
In setting out to detect how aerosols form and grow in an agricultural region of Oklahoma, the team of scientists behind this recent study stumbled across trace amounts of MCCPs in the atmosphere. They detected these particles using a technique known as nitrate ion chemical ionization mass spectrometry, and the results were published last week in the journal ACS Environmental AU.
MCCPs start their lives within things like metalworking fluids, textiles, and PVC, which is why they can often find themselves in wastewater. That's a problem, because a fertilizer known as biosolids (which is made from treated sewar sludge) is often spread across agricultural crops.
'When sewage sludges are spread across the fields, those toxic compounds could be released into the air,' Daniel Katz, lead author of the study, said in a press statement. 'We can't show directly that that's happening, but we think it's a reasonable way that they could be winding up in the air. Sewage sludge fertilizers have been shown to release similar compounds.'
The creation of this synthetic chemical was in large part due to the regulation of its toxic cousin, Short Chain Chlorinated Paraffins (SCCPs), which have been regulated by the Environmental Protection Agency (EPA) and the Stockholm Convention (an international body formed in 2001 to protect human health against persistent organic pollutants). Earlier this year, the Stockholm Convention also marked MCCPs for global elimination. Who knows if this will spawn the creation of another toxic chemical, but this regulatory game of whack-a-mole is similar in the truly Sisyphean task of trying to eliminate PFAS from the environment.
'We always have these unintended consequences of regulation, where you regulate something, and then there's still a need for the products that those were in,' Ellie Browne, a co-author of the study, said in a press statement. 'So they get replaced by something.'
Luckily, there is some good news. The Oklahoma Senate passed a bill earlier this year eliminating biosolids as a fertilizer, and a newly established environmental group called The Coalition for Sludge-Free Land aims to make the ban a national one (the EPA currently regulates, but doesn't ban, the substance). Now that MCCPs have been found in the atmosphere, the UC Boulder team hopes that future efforts will be able to discern their airborne impact.
'We identified them, but we still don't know exactly what they do when they are in the atmosphere, and they need to be investigated further,' Katz said in a press statement. 'I think it's important that we continue to have governmental agencies that are capable of evaluating the science and regulating these chemicals as necessary for public health and safety.'
You Might Also Like
The Do's and Don'ts of Using Painter's Tape
The Best Portable BBQ Grills for Cooking Anywhere
Can a Smart Watch Prolong Your Life?
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 hours ago
- Yahoo
Lung Cancer Screening Market to Reach USD 7.44 Billion by 2032, Driven by LDCT Adoption and Growing High-Risk Population
Global Lung Cancer Screening Market Forecast (2025–2032) Shows 9.32% CAGR, U.S. Market to Hit USD 2.21 Billion by 2032 Amid Early Detection Demand and Technological Advancements. Austin, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Lung Cancer Screening Market Size & Growth Analysis: According to SNS Insider, The Lung Cancer Screening Market was estimated at USD 3.66 billion in 2024 and is expected to reach USD 7.44 billion by 2032, at a CAGR of 9.32% during the forecast period of 2025-2032. The global lung cancer screening market growth is driven by the increasing prevalence of lung cancer and growing adoption of screening, initiatives to increase awareness about lung cancer, and the introduction of new and advanced products. Favorable governmental policies, rising healthcare infrastructure, and technological advancements are other factors driving Free Sample Report of the Lung Cancer Screening Market: The U.S. lung cancer screening market was estimated at USD 1.12 billion in 2024 and is expected to reach USD 2.21 billion by 2032, at a CAGR of 8.89% during the forecast period of 2025-2032 The U.S. dominated the North American lung cancer screening market, driven by robust policy support and early uptake of low-dose computed tomography (LDCT) among the eligible high-risk population of 50 to 80-year-olds with a smoking history of 20+ pack-years under updated USPSTF guidelines. Segmentation & Regional Highlights By Modality, the LDCT Segment Dominates the Lung Cancer Screening Market in 2024 The low-dose computed tomography (LDCT) segment held the largest share of the lung cancer screening market in 2024 with a 61.2% market share owing to high accuracy, non-invasive nature, and support by such as the U.S. Preventive Services Task Force (USPSTF) and other major health societies. LDCT allows early lung cancer diagnosis in high-risk patients and dramatically improves survival. Incorporation of cancer screening and insurance coverage has facilitated adoption, particularly in the developed world. By Cancer Type, the Non-Small Cell Lung Cancer (NSCLC) Segment Dominates the Market and is Witnessing High Growth Over the Forecast Period Non-small cell lung cancer (NSCLC) segment held a major share of the lung cancer screening market in 2024 as a result of the high prevalence of NSCLC among the population, which accounts for nearly 85% of all lung cancer cases around the globe. NSCLC is slow compared to small cell lung cancer, making it possible for more cases to be found early and diagnosed during screening. The demand for NSCLC screening has also increased with the development of targeted therapies and biomarkers for NSCLC. The 60–69 Years Segment Dominated the Lung Cancer Screening Market by Age Group The 60–69 years age group dominated the Lung Cancer Screening Market in the year 2024, owing to the higher prevalence of lung cancer in this age group. Members of this group are usually longer-term smokers or have had more exposure to carcinogens, and are therefore at higher risk, justifying the need for regular screening. Many countries' medical guidelines give this age range priority for low-dose CT screening, which has driven an increase in use. Lung Cancer Screening Market in North America Led in 2024 with a 40.3% Market Share, APAC Poised to be the Fastest-Growing Regional Market. The lung cancer screening market in North America is driven by the well-developed healthcare system, early uptake of advanced screening technologies such as LDCT, and favorable reimbursement scenarios. Marked awareness of lung cancer, full-scale enforcement of national screening guidelines, and a strong position of key players provide additional prospects for regional supremacy. Screening programmes promoted by governmental institutions such as the U.S. Preventive Services Task Force (USPSTF) have increased the screening rates, especially in high-risk individuals, and the region has evolved into a global market leader. The Asia-Pacific lung cancer screening market is estimated to register the highest CAGR, on account of a rise in the incidence of lung cancer, increasing awareness, and the increasing healthcare expenditure in the region. China, India, Japan, and other countries are enhancing early cancer screening initiatives, expanding access to LDCT and biomarker testing. For a Personalized Briefing with Our Industry Analysts, Connect Now: Key Lung Cancer Screening Companies Profiled in the Report GE HealthCare Siemens Healthineers Philips Healthcare Canon Medical Systems Corporation Fujifilm Holdings Corporation Samsung Medison Co. Ltd. Carestream Health Shimadzu Corporation Vuno Inc. Zebra Medical Vision Aidoc Riverain Technologies Lunit Inc. Roche Diagnostics Illumina Inc. Guardant Health Exact Sciences Corporation Bio-Rad Laboratories CT Screening International and other players. Lung Cancer Screening Market Report Scope Report Attributes Details Market Size in 2024 US$ 3.66 billion Market Size by 2032 US$ 7.44 billion CAGR CAGR of 9.32% From 2025 to 2032 Base Year 2024 Forecast Period 2025-2032 Historical Data 2021-2023 Regional Analysis North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Poland, Turkey, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) Key Growth Drivers Growing incidence of lung cancer worldwide Increased public awareness and government-led screening programs Advancements in imaging technologies (e.g., AI-enabled CT scans) Rising demand for non-invasive and early-stage cancer detection Supportive reimbursement policies in the U.S. and Europe Unique Selling Propositions (USPs) of the Report: Country-level eligibility for the screening landscape Assists your company in prioritizing markets that have high potential opportunity by comparing age, risk, and reimbursement criteria for screening across countries. Adoption curves comparison: LDCT vs. new technologies Facilitates strategic planning by identifying lung cancer screening early adopters vs. laggards for LDCT and next-gen technologies, and helps to launch market entry timing. Biomarker Inclusion in Lung Screening Helps companies make R&D and partnership decisions by monitoring how molecular diagnostics are supplementing or undercutting traditional screening. RoS (Return on Screening) Modelling Measures the cost per site of value of your screening programs to enable XYZ Company to create a persuasive business case for customers or reimbursement agencies, or health authorities. Buy the Full Lung Cancer Screening Market Report (Single-User License) Now: About Us: SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world. CONTACT: Contact Us: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK) Email: info@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Newsweek
a day ago
- Newsweek
Millions of Children Across 13 States Told To Limit Outdoor Activity
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Air quality alerts spanned at least 13 U.S. states on Tuesday, with sensitive groups urged to limit outdoor activity to avoid health risks. Why It Matters According to the Environmental Protection Agency, studies have linked particle pollution exposure to various health effects, including respiratory symptoms—such as coughing and wheezing, the development of asthma and increased susceptibility to respiratory infections. Authorities advise that during periods of poor air quality, sensitive groups—including children, older adults and those with certain preexisting conditions—should limit prolonged or heavy outdoor exertion. What To Know In collaboration with local agencies, the National Weather Service (NWS) published air quality alerts for the following states as of Tuesday morning: California Colorado Texas Minnesota Wisconsin Michigan Indiana Ohio Pennsylvania New York Connecticut Vermont New Hampshire Alerts spanned the entirety of Michigan and Wisconsin because of smoke from Canadian wildfires. "The main culprit remains Canadian wildfire smoke, originating from the Manitoba and Ontario Provinces. The second culprit is a stubborn high-pressure cell planted over the Midwest which is holding the smoke in place and compressing it close to the ground," said a notice from the Michigan Department of Environmental Quality, which the NWS published. "The weak clockwise winds will recirculate the worst of the smoke westward then northward, back into the western U.P., but the entire state will remain under hazy conditions during Tuesday," it continued. Northeast Minnesota and eastern Pennsylvania were also affected by wildfire smoke, according to alerts for the regions. Particle pollution—a product of wildfires—was also the cause of air quality alerts in Indiana, Vermont, New Hampshire and Colorado. Wildfire smoke from Canada will be on the increase over the next 24 hours. This is a model depiction of smoke in the atmosphere. Orange colors indicate thicker smoke, representing more hazy skies. #mewx #nhwx — NWS Gray (@NWSGray) August 2, 2025 In California, the South Coast Air Quality Management District issued a wildfire smoke advisory as multiple blazes burn in both central and Southern California. This included the 72,460-acre Gifford fire affecting parts of San Luis Obispo and Santa Barbara Counties, as well as the Rosa fire near the Santa Rosa Mountains and the Gold fire in the San Bernadino National Forest, north of Big Bear Lake. Here's a projection for the smoke from the #GiffordFire 🔥in San Luis Obispo/Santa Barbara Counties through tomorrow night. Smoke will generally move towards the south and east. — NWS Los Angeles (@NWSLosAngeles) August 4, 2025 Meanwhile, air quality alerts were in place in Texas and Ohio because of ozone pollution. In Ohio, this affected Ashtabula, Cuyahoga, Geauga, Lake, Lorain, Medina, Portage and Summit Counties. In Texas, alerts applied to both the Dallas-Fort Worth and Houston-Galveston areas. What People Are Saying AccuWeather meteorologist Dan Pydynowski told Newsweek on Friday: "Smoke and haze creating poor air quality at times will likely continue to be an issue in [the Great Lakes, Upper Midwest and central U.S.] through the weekend and into early next week. "The smoke/haze will gradually spread south and east later this weekend into early next week as well, perhaps getting into parts of the Northeast U.S. and the central-southern Plains too." The National Weather Service account for Burlington, Vermont, wrote on X on Thursday: "Air Quality Alerts continue for New York and Vermont. Some cleaner air is mixing in from the north compared to recent days, but some smoke will remain with higher concentrations expected in southern portions of the region." What Happens Next The NWS regularly issued forecast updates on its website.
Newsweek
a day ago
- Newsweek
These Common Chemicals Could Be Harming Your Liver
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A new review has found that exposure to particular chemicals can, when combined, enhance damage to the liver. The researchers of the July 2025 review, published in Toxicological Sciences, found that both alcohol and PFAS chemicals—a group of widely-used compounds—damage the liver in similar ways. This could be "causing fat buildup, inflammation, and oxidative stress," Vasilis Vasiliou, one of the authors of the review, and chair and professor of environmental health sciences at Yale School of Public Health, told Newsweek. While alcohol is a well-established cause of liver disease, PFAS chemicals may "act as a 'second hit,' especially in people who already drink alcohol or have other liver risk factors," he added. PFAS chemicals, also known as "forever chemicals" or Per- and polyfluoroalkyl substances, have been classified by the International Agency for Research on Cancer as a Group 1 carcinogen—with studies since finding the chemicals can cause a wide range of effects on public health. These chemicals can be found across various industries and consumer products, from nonstick cookware, waterproof clothing and stain-resistant furniture, to food packaging and even smartwatch wristbands. They can also be found in drinking water sources across the country. According to the review's researchers, detectable levels of PFAS chemicals have been found in over 98 percent of the human population. Meanwhile, more than half of all Americans drink alcohol—with 17 percent binge drinking, meaning, for women, they have four or more drinks on one occasion, while for men, they have five or more drinks, according to Centers for Disease Control and Prevention (CDC) data. Per the CDC's data, 6 percent also drink heavily, meaning, for women, they have eight or more drinks in a week and for men, they have 15 or more drinks. According to the review's researchers, while global consumption of alcohol has been decreasing since 2010, in the U.S. there has been an increase in consumption, meaning it is now nearly double the global average. File photo: A gastroenterologist doctor explaining liver and gallbladder problems using an anatomical model to a patient during a clinic visit. File photo: A gastroenterologist doctor explaining liver and gallbladder problems using an anatomical model to a patient during a clinic visit. peakSTOCK/Getty Images What The Review Found When people are exposed to both alcohol and PFAS chemicals, these "effects can add up or even multiply, leading to more serious liver injury," Vasiliou said. He added that vulnerable populations, or those with limited health care access, are particularly at risk. "Our review suggests that PFAS exposure may worsen the damage already caused by alcohol, raising the risk of progression from fatty liver to more severe conditions like cirrhosis or liver cancer," he said. The review noted that around two million deaths a year are estimated to occur due to advanced liver disease, predominantly cirrhosis and hepatocellular carcinoma, with alcohol consumption being a significant risk factor for these conditions. Alcohol contributed to nearly half of all cirrhosis deaths and over 150,000 new cases of liver cancer globally in 2016. "The findings are not unexpected," Dr. Suthat Liangpunsakul, a professor of medicine and of biochemistry and molecular biology at the Indiana University School of Medicine, told Newsweek. "Both alcohol and PFAS have independently been shown to affect the liver through mechanisms such as oxidative stress, lipid dysregulation, and mitochondrial dysfunction," Liangpunsakul said. "Given these overlapping pathways, the possibility that combined exposures may exacerbate liver injury is a reasonable hypothesis," he added. Liangpunsakul said the study therefore "brings together existing evidence in a way that highlights the need for further investigation." It adds to the "body of literature suggesting that multiple exposures, including lifestyle and environmental factors, can interact in complex ways to affect liver health," he said. However, "further research, particularly in human populations, will be important to better characterize these interactions and their potential clinical implications," he added. Vasiliou said that he and the other researchers in the laboratory are continuing to investigate the impact of PFAS chemicals on the liver in animal models and intend to expand research to human studies. In this photo illustration, water flows from a tap on July 06, 2023 in San Anselmo, California. In 2023, a study by the US Geological Survey found that nearly half of the tap water in... In this photo illustration, water flows from a tap on July 06, 2023 in San Anselmo, California. In 2023, a study by the US Geological Survey found that nearly half of the tap water in the United States was contaminated with "forever chemicals," considered dangerous to human health. More/Getty Images How PFAS Chemicals And Alcohol Could Harm The Liver PFAS chemicals may harm the liver by "disturbing fat metabolism, damaging mitochondria, increasing oxidative stress, and triggering inflammation," Vasiliou said, adding these were many of the same processes affected by alcohol. Liangpunsakul also said that PFAS chemicals "can accumulate in the liver" and cause the same problems mentioned by Vasiliou. Meanwhile, "alcohol has long-established and well-characterized hepatotoxic effects, particularly in the setting of chronic use," Liangpunsakul said. Therefore, the "real danger lies in their combined impact," Vasiliou said. "Together, they can accelerate liver damage in ways that neither might do alone." Liangpunsakul said that it is difficult to compare the "relative toxicity" of alcohol and PFAS, "as they operate under different exposure contexts and time courses." However, based on the review, he said that "PFAS may contribute additional stress to the liver, particularly in individuals with other risk factors such as alcohol use." While PFAS chemicals are in a wide range of everyday products, the most common way people are exposed to PFAS chemicals is through ingestion, Vasiliou said. "PFAS often enter our bodies through contaminated drinking water; food, especially fish [and] meat; fast-food packaging; and household products like nonstick cookware or stain-resistant fabrics," he said. Once ingested, PFAS chemicals can "circulate in the blood and accumulate in the liver, where they can persist for years due to their resistance to breakdown," he added. Those who are also occupationally exposed to the chemicals due to their work, such as firefighters or factory workers, may also "inhale PFAS or absorb them through the skin," he said. How Could The Research Shape The Treatment of Liver Disease? Liangpunsakul said the review highlights a growing area of scientific interest—"how environmental exposures might interact with more traditional risk factors like alcohol." He said that while "it is too early to say how this will influence clinical practice," the findings "may help guide future research into liver disease progression and its multifactorial drivers." "Improved understanding of co-exposures could eventually contribute to more refined risk assessment strategies," he added. The research also suggests that increasing awareness on individual PFAS exposure may become an important part of maintaining health. "For people with liver risk factors, such as alcohol abuse use or obesity, minimizing PFAS exposure could be especially important," Vasiliou said. However, "avoiding PFAS completely is difficult because they are so widespread, but people can take steps to reduce exposure," he added. He said individuals can use PFAS-free cookware and personal care products, filter drinking water with systems certified to remove PFAS, and check local advisories about contaminated water or fish. On a broader level, Vasiliou said that "stronger policies and better regulation are needed to reduce PFAS in our environment." Reference Arthur D Stem, Ricardo Scheufen Tieghi, Vaia Lida Chatzi, Nicole Kleinstreuer, Damaskini Valvi, David C Thompson, Vasilis Vasiliou, (2025). Synergistic Toxicity in Alcohol-Associated Liver Disease and PFAS Exposure, Toxicological Sciences,
